4//SEC Filing
HOBDEN ADRIAN N 4
Accession 0001191076-09-000004
CIK 0000899923other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:07 PM ET
Size
10.4 KB
Accession
0001191076-09-000004
Insider Transaction Report
Form 4
HOBDEN ADRIAN N
Pres. Myriad Pharmaceuticals
Transactions
- Exercise/Conversion
Common Stock
2009-05-08$5.37/sh+12,502$67,136→ 190,486 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2009-05-08−12,502→ 0 totalExercise: $5.37From: 2006-02-13Exp: 2013-02-13→ Common Stock (12,502 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2009-05-08−5,240→ 0 totalExercise: $6.27Exp: 2013-09-09→ Common Stock (5,240 underlying) - Exercise/Conversion
Common Stock
2009-05-08$6.27/sh+5,240$32,855→ 195,726 total
Footnotes (1)
- [F1]The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
Documents
Issuer
MYRIAD GENETICS INC
CIK 0000899923
Entity typeother
Related Parties
1- filerCIK 0001191076
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:07 PM ET
- Size
- 10.4 KB